CoChat
Sign Up
Cited by 133

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington’s disease

Valenza, M, Marullo, M, Di Paolo, E, Cesana, E, Zuccato, C, Biella, G, Cattaneo, E·2015·Cell Death & Differentiation
DOI 10.1038/cdd.2014.162
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/cdd.2014.162

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 56

  1. Zuccato C, Valenza M, Cattaneo E . Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev 2010; 90: 905–981. · DOI · Paper page
  2. Dietschy JM, Turley SD . Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 2004; 45: 1375–1397. · DOI · Paper page
  3. Porter FD, Herman GE . Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res 2011; 52: 6–34. · DOI · Paper page
  4. Suzuki R, Ferris HA, Chee MJ, Maratos-Flier E, Kahn CR . Reduction of the cholesterol sensor SCAP in the brains of mice causes impaired synaptic transmission and altered cognitive function. PLoS Biol 2013; 11: e1001532. · DOI
  5. Valenza M, Cattaneo E . Emerging roles for cholesterol in Huntington's disease. Trends Neurosci 2011; 34: 474–486. · DOI
  6. Karasinska JM, Hayden MR . Cholesterol metabolism in Huntington disease. Nat Rev Neurol 2011; 7: 561–572. · DOI · Paper page
  7. Valenza M, Rigamonti D, Goffredo D, Zuccato C, Fenu S, Jamot L et al. Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease. J Neurosci 2005; 25: 9932–9939. · DOI · Paper page
  8. Valenza M, Leoni V, Karasinska JM, Petricca L, Fan J, Carroll J et al. Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes. J Neurosci 2010; 30: 10844–10850. · DOI · Paper page
  9. Leoni V, Mariotti C, Tabrizi SJ, Valenza M, Wild EJ, Henley SM et al. Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease. Brain 2008; 131: 2851–2859. · DOI
  10. Leoni V, Long JD, Mills JA, Di Donato S, Paulsen JS . PREDICT-HD study group Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression. Neurobiol Dis 2013; 55: 37–43. · DOI
  11. Mauch DH, Nagler K, Schumacher S, Goritz C, Muller EC, Otto A et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001; 294: 1354–1357. · DOI · Paper page
  12. Hebb MO, Denovan-Wright EM, Robertson HA . Expression of the Huntington's disease gene is regulated in astrocytes in the arcuate nucleus of the hypothalamus of postpartum rats. FASEB J 1999; 13: 1099–1106. · DOI
  13. Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, Li XJ . Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 2005; 171: 1001–1012. · DOI
  14. Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S . Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci USA 2009; 106: 22480–22485. · DOI
  15. Bradford J, Shin JY, Roberts M, Wang CE, Sheng G, Li S et al. Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J Biol Chem 2010; 285: 10653–10661. · DOI
  16. Conforti P, Camnasio S, Mutti C, Valenza M, Thompson M, Fossale E et al. Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death. Neurobiol Dis 2013; 50: 160–170. · DOI
  17. Valenza M, Carroll JB, Leoni V, Bertram LN, Bjorkhem I, Singaraja RR et al. Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. Hum Mol Genet 2007; 16: 2187–2198. · DOI · Paper page
  18. Spiliotopoulos D, Goffredo D, Conti L, Di Febo F, Biella G, Toselli M et al. An optimized experimental strategy for efficient conversion of embryonic stem (ES)-derived mouse neural stem (NS) cells into a nearly homogeneous mature neuronal population. Neurobiol Dis 2009; 34: 320–331. · DOI
  19. Pool M, Thiemann J, Bar-Or A, Fournier AE . NeuriteTracer: a novel ImageJ plugin for automated quantification of neurite outgrowth. J Neurosci Methods 2008; 168: 134–139. · DOI
  20. Jansen PJ, Lutjohann D, Thelen KM, von Bergmann K, van Leuven F, Ramaekers FC et al. Absence of ApoE upregulates murine brain ApoD and ABCA1 levels, but does not affect brain sterol levels, while human ApoE3 and human ApoE4 upregulate brain cholesterol precursor levels. J Alzheimers Dis 2009; 18: 319–329. · DOI
  21. Miserez AR, Cao G, Probst LC, Hobbs HH . Structure of the human gene encoding sterol regulatory element binding protein 2 (SREBF2). Genomics 1997; 40: 31–40. · DOI
  22. Pfrieger FW . Role of glial cells in the formation and maintenance of synapses. Brain Res Rev 2010; 63: 39–46. · DOI · Paper page
  23. Hayashi H, Campenot RB, Vance DE, Vance JE . Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures. J Biol Chem 2004; 279: 14009–14015. · DOI
  24. Goritz C, Thiebaut R, Tessier LH, Nieweg K, Moehle C, Buard I et al. Glia-induced neuronal differentiation by transcriptional regulation. Glia 2007; 55: 1108–1122. · DOI
  25. Buard I, Steinmetz CC, Claudepierre T, Pfrieger FW . Glial cells promote dendrite formation and the reception of synaptic input in Purkinje cells from postnatal mice. Glia 2010; 58: 538–545. · DOI
  26. Fan QW, Yu W, Gong JS, Zou K, Sawamura N, Senda T et al. Cholesterol-dependent modulation of dendrite outgrowth and microtubule stability in cultured neurons. J Neurochem 2002; 80: 178–190. · DOI
  27. Tong J, Huang C, Bi F, Wu Q, Huang B, Liu X et al. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J 2013; 32: 1917–1926. · DOI
  28. Ballas N, Lioy DT, Grunseich C, Mandel G . Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 2009; 12: 311–317. · DOI · Paper page
  29. Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK et al. A role for glia in the progression of Rett's syndrome. Nature 2011; 475: 497–500. · DOI · Paper page
  30. Di Malta C, Fryer JD, Settembre C, Ballabio A . Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder. Proc Natl Acad Sci USA 2012; 109: E2334–E2342. · DOI
  31. Furman JL, Sama DM, Gant JC, Beckett TL, Murphy MP, Bachstetter AD et al. Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease. J Neurosci 2012; 32: 16129–16140. · DOI · Paper page
  32. Tong X, Ao Y, Faas GC, Nwaobi SE, Xu J, Haustein MD et al. Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. Nat Neurosci 2014 Mar: 30. · DOI · Paper page
  33. Hughes EG, Elmariah SB, Balice-Gordon RJ . Astrocyte secreted proteins selectively increase hippocampal GABAergic axon length, branching, and synaptogenesis. Mol Cell Neurosci 2010; 43: 136–145. · DOI
  34. Karasinska JM, Rinninger F, Lutjohann D, Ruddle P, Franciosi S, Kruit JK et al. Specific loss of brain ABCA1 increases brain cholesterol uptake and influences neuronal structure and function. J Neurosci 2009; 29: 3579–3589. · DOI · Paper page
  35. Cermenati G, Brioschi E, Abbiati F, Melcangi RC, Caruso D, Mitro N . Liver X receptors, nervous system, and lipid metabolism. J Endocrinol Invest 2013; 36: 435–443.
  36. Futter M, Diekmann H, Schoenmakers E, Sadiq O, Chatterjee K, Rubinsztein DC . Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors. J Med Genet 2009; 46: 438–446. · DOI
  37. Camargo N, Smit AB, Verheijen MH . SREBPs: SREBP function in glia-neuron interactions. FEBS J 2009; 276: 628–636. · DOI
  38. Verheijen MH, Camargo N, Verdier V, Nadra K, de Preux Charles AS, Medard JJ et al. SCAP is required for timely and proper myelin membrane synthesis. Proc Natl Acad Sci USA 2009; 106: 21383–21388. · DOI · Paper page
  39. Camargo N, Brouwers JF, Loos M, Gutmann DH, Smit AB, Verheijen MH . High-fat diet ameliorates neurological deficits caused by defective astrocyte lipid metabolism. FASEB J 2012; 26: 4302–4315. · DOI
  40. Bjorkhem I . Do oxysterols control cholesterol homeostasis? J Clin Invest 2002; 110: 725–730. · DOI
  41. Cummings DM, Cepeda C, Levine MS . Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease. ASN neuro 2010; 2: e00036. · DOI
  42. Milnerwood AJ, Raymond LA . Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease. Trends Neurosci 2010; 33: 513–523. · DOI
  43. Orth M, Schippling S, Schneider SA, Bhatia KP, Talelli P, Tabrizi SJ et al. Abnormal motor cortex plasticity in premanifest and very early manifest Huntington disease. J Neurol Neurosurg Psychiatry 2010; 81: 267–270. · DOI
  44. Valenza M, Leoni V, Tarditi A, Mariotti C, Bjorkhem I, Di Donato S et al. Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington's disease. Neurobiol Dis 2007; 28: 133–142. · DOI · Paper page
  45. Pfrieger FW . Role of cholesterol in synapse formation and function. Biochim Biophys Acta 2003; 1610: 271–280. · DOI · Paper page
  46. Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005; 120: 421–433. · DOI · Paper page
  47. Funfschilling U, Jockusch WJ, Sivakumar N, Mobius W, Corthals K, Li S et al. Critical time window of neuronal cholesterol synthesis during neurite outgrowth. J Neurosci 2012; 32: 7632–7645. · DOI
  48. Hulce JJ, Cognetta AB, Niphakis MJ, Tully SE, Cravatt BF . Proteome-wide mapping of cholesterol-interacting proteins in mammalian cells. Nature methods 2013; 10: 259–264. · DOI
  49. Nieweg K, Schaller H, Pfrieger FW . Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J Neurochem 2009; 109: 125–134. · DOI · Paper page
  50. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA . Control of synapse number by glia. Science 2001; 291: 657–661. · DOI · Paper page
  51. Sodero AO, Vriens J, Ghosh D, Stegner D, Brachet A, Pallotto M et al. Cholesterol loss during glutamate-mediated excitotoxicity. EMBO J 2012; 31: 1764–1773. · DOI
  52. Taghibiglou C, Martin HG, Lai TW, Cho T, Prasad S, Kojic L et al. Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries. Nat Med 2009; 15: 1399–1406. · DOI
  53. Aono M, Lee Y, Grant ER, Zivin RA, Pearlstein RD, Warner DS et al. Apolipoprotein E protects against NMDA excitotoxicity. Neurobiol Dis 2002; 11: 214–220. · DOI
  54. Paul SM, Doherty JJ, Robichaud AJ, Belfort GM, Chow BY, Hammond RS et al. The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors. J Neurosci 2013; 33: 17290–17300. · DOI
  55. del Toro D, Xifro X, Pol A, Humbert S, Saudou F, Canals JM et al. Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease. J Neurochem 2010; 115: 153–167. · DOI
  56. Colella AD, Chegenii N, Tea MN, Gibbins IL, Williams KA, Chataway TK . Comparison of stain-free gels with traditional immunoblot loading control methodology. Anal Biochem 2012; 430: 108–110. · DOI

Cited by

Sorted by citations

Metadata

Authors
Valenza, M., Marullo, M., Di Paolo, E., Cesana, E., Zuccato, C., Biella, G., & Cattaneo, E.
Venue
Cell Death & Differentiation
Publisher
Springer Science and Business Media LLC
Published
2014-10-10
Volume
22
Issue
4
Pages
690-702
ISSN
  • 1350-9047
  • 1476-5403
DOI
10.1038/cdd.2014.162
Cited by
133
References
6
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review